Frontlight ResearchEarly access
Trial site
Hubei Cancer Hospital
- 4running trials
- 3closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Gastric and oesophageal cancer2 trials
- Lung cancer2 trials
- Ovarian cancer2 trials
- Diffuse large B-cell lymphoma1 trial
- Phase
- Phase 23 trials
- Phase 32 trials
- Status
- Active, not recruiting3 trials
- Completed3 trials
- Recruiting1 trial
- Lead sponsor
- Daiichi Sankyo2 trials
- BeiGene1 trial
- Daiichi Sankyo Co., Ltd.1 trial
- Genmab1 trial
- Haihe Biopharma Co., Ltd.1 trial
- and 1 more
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer1 recruiting
Closed trials
Completed
Completed
Completed
Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian
Site data: ClinicalTrials.govUpdated 12 Nov 2026